Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma

Figure 3

The relationship between SLCO4A1 expression levels and COAD patients’ prognosis. (a) OS and (b) DFS of COAD patients based on SLCO4A1 expression levels via GEPIA. (c) OS and (d) DFS of COAD patients based on SLCO4A1 expression levels via the Kaplan-Meier plotter. (e) OS, (f) DFS, and (g) DDS of COAD patients based on SLCO4A1 expression levels via the PrognoScan database. OS: overall survival; DFS: disease-free survival; DSS: disease-specific survival.

(a)

(b)

(c)

(d)

(e)

(f)

(g)